Figure 2.
Figure 2. Algorithm for evaluation of MPN phenotype without erythrocytosis. *Test JAK2 V617F first, CALR mutations if V617F is negative, and MPL mutations if JAK2 and CALR are negative. **Evaluate for MPN, MDS, MDS/MPN, or other myeloid malignancies.

Algorithm for evaluation of MPN phenotype without erythrocytosis. *Test JAK2 V617F first, CALR mutations if V617F is negative, and MPL mutations if JAK2 and CALR are negative. **Evaluate for MPN, MDS, MDS/MPN, or other myeloid malignancies.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal